ARTICLE | Company News
CPEX drug delivery, endocrine news
October 4, 2010 7:00 AM UTC
CPEX said it is continuing to seek strategic alternatives, including a sale, merger or "other business combination" or monetization of CPEX's assets. CPEX's Nasulin intranasal insulin is in Phase II ...